Importantly, high expression of RCC1 was significantly correlated with poor clinical outcome, as evidenced by lower overall survival in pancreatic cancer patients with high RCC1 expression (Fig. 5B), suggesting that RCC1 might play a major role in pancreatic cancer development. The gene discussed is RCC1; the disease is familial pancreatic carcinoma.